Last year, I got an email from this company but it was a more personal question relating to things they might work on in the future. The person replying was Gil.
It does help to make sure the email makes sense. They aren't going to issue updates to individual investors since that's insider trading, although they might direct you to the site, I suppose. And it wouldn't help if the grammar of the email is similar to rahdbob3's post.
At least no news means that the deal hasn't been officially cancelled, and if the deadline passes without a news release, once again we can at least conclude there's potential for a deal and that negotiations are ongoing...
I was thinking that it would be more like "Goldfinger".. when it gets to 007 we will get the news. If not, we may see this thing really blow up!
I think that day 120 will come and go with no changes. It is almost like Brigadoon. This may not be a problem as a poster aptly put it "nothing happens in the summer throughout the industry."
well, hard to say what is going to happen next here.....I do think we hear some good news at the upcoming CC on Aug 6 in some manner.....they have been awfully quiet for a while here, but I think that is about to change......perhaps they will be rolling out another plan in the right direction to get things moving around here..... : D.....exterminators, cats, and the Pied Piper would love to see them go the direction you are suggesting though....
I've been in ATHX for years and completely abandoned the stock and news for this company in April. Just thought to come back and see how things are.
Gil should really just stop wasting $ on clinicals, or sell multistem as a treatment for rats who get mini strokes...they'll make more money that way lol.
I marked Strong Buy so the bots can upvote, but I really don't care
Sentiment: Strong Buy
Why are you such a negative douche? Ive been trying ignore your posts and not validate your opinion. That said,please remember that opinions r like #$%$ everyone has one! You seem to spend an inordinate amount of time pssing all over this board...get a different hobby!
I'm not a doctor nor scientist, so most of this is beyond my paygrade BUT having spent many years on the street with biotech research boutiques, this GVHD release reads extremely positive. I remember reading someplace that ATHX has already been granted some sort of orphan drug status relating to GVHD. Some of the other posts I've read relating to ARDS preliminary studies read positive, as well. IMHO, MS for IS is the focus and quickest path to commercialization $$ via Chugai BUT let's not loose focus relating to other far reaching applications that potentially could change the landscape in the future...ATHX is not just a one trick pony!
Join the club! Two small doses separated by 8 weeks to cure a long-term autoimmune disease? Laughable!
I have been doing some work on the ulcerative colitis, Phase 2 and I wasn't at all impressed with Pfizer's sponsorship of NCT01240915.
and just like I always say "summer is selling season for Athersys".
All in my honest opinion.
Sentiment: Strong Sell